Elon Musk, the co-founder of Neuralink, announced a milestone achievement for the brain implant technology firm. The first human implant by Neuralink has been successfully executed.
What Happened: In a post on X, formerly Twitter, on Monday, Musk revealed that Neuralink had successfully implanted a human brain for the first time. He stated that the patient was recovering well and the initial results demonstrated promising neuron spike detection.
The Musk-associated startup’s PRIME study is testing the wireless brain-computer interface to establish the safety of both the implant and the surgical robot, reported Reuters.
The study will examine the interface that reportedly allows people with quadriplegia to manipulate devices with just their thoughts alone.
On Monday, Musk revealed that the first Neuralink product is called “Telepathy” and that it enables control of a phone or computer and through them almost any device, just by thinking.
“Imagine if Stephen Hawking could communicate faster than a speed typist or auctioneer. That is the goal.”
Why It Matters: Neuralink’s technology, including its N1 implant and R1 surgical robot, has the potential to revolutionize treatment for neurodegenerative disorders such as ALS, as per Ark Investment Management.
Despite recent regulatory challenges with the U.S. Department of Transportation over hazardous material transportation violations, as per a Benzinga Report, Neuralink has continued to secure funding. The firm raised an additional $43 million in November.
Musk has long advocated for the merging of man and machine to survive in a world dominated by artificial intelligence, as he discussed in a 2018 interview. This recent breakthrough could bring us a step closer to his vision.
Image Via Shutterstock
Engineered by Benzinga Neuro, Edited by Shivdeep Dhaliwal
The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. Learn more.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
